Cultural Committee Chairperson of Emirates Pathology Society

Professor of Pathology, Consultant Anatomic Pathologist,

College of Medicine, University of Sharjah

United Arab Emirates

Scientific Committee Chairperson of Emirates Pathology Society

Consultant Anatomic Pathologist, H.H. Sheikh Khalifa Specialty Hospital

United Arab Emirates

Andrey Bychkov, MD, PhD, FRCPath is a Director of Digital Pathology at Kameda Medical Center, Kamogawa, Japan and a Visiting Associate Professor at Nagasaki University. Dr. Bychkov graduated with an M.D. from Russia where he also completed residency training and practiced in anatomic pathology. Later, he earned a Ph.D. in molecular medicine in Nagasaki, Japan and supervised research projects at Chulalongkorn University, Thailand.

His subspecialty is thyroid pathology and he has contributed to the 2022 WHO classifications of Endocrine and Hematolymphoid tumors. Dr. Bychkov is deeply involved in the development of the Kameda Digital Pathology Network, which is one the few Asian facilities successfully adopted digital pathology and AI for primary diagnosis.

Dr. Bychkov has published extensively and has authored more than 100 journal articles and book chapters. He is an academic editor for several international journals (PLOS One, IJSP, JPTM, etc.) and regularly presents at various conferences and pathology meetings, including top-ranked events, such as USCAP, IAP, IAC, and others.

Dr. Fouad Al Dayel is currently the Chairman of the Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia since 2003. He is also the Deputy International Commissioner for Middle East, College of American Pathologists since 2014. As Consultant Anatomic Pathologist, Dr. Al Dayel’s special interests are lung pathology, bone & soft tissue pathology, cell therapy and molecular pathology. Dr. Al Dayel is also interested in laboratory quality management and laboratory accreditations.

Dr. Al Dayel main research interest is solid tumors cancer genome. He published more than 184 articles in peer reviewed journals.

United Arab Emirates

United Arab Emirates

Hyo Jin Park, M.D., Ph.D. is a Consultant Pathologist at Sheikh Khalifa Specialty Hospital (SKSH). She is affiliated at Seoul National University (SNU) Hospital in Korea as a Clinical Assistant Professor. Dr. Park earned her M.D. degree in 1998 and her Ph.D. in 2010 from SNU, College of Medicine. She completed her residency training at SNU hospital and obtained board certification as an anatomic pathologist in 2005. Since 2015, she has been actively contributing to the pathology department at SKSH and played a key role in implementing genetic tests on solid tumor using next generation sequencing. Her primary areas of interest include breast, lung, endocrine and molecular pathology. She has published many articles in SCI journals.

Having studied and received a Ph.D. in theoretical physics, Prof. Busch has been working in Systems Biology and Bioinformatics since 2004. His main research interests are in the modeling of signaling pathways and integrative Omics analysis of high throughput data with applications in precision oncology, inflammation, genetics, microbiome analysis, and movement disorders. As such, he is the head of the Systems Biology service and single-cell core unit of the University of Lübeck. He leads the Bioinformatics and translational research of the Molecular Tumor Board of the University Hospital Schleswig-Holstein, the second-largest hospital in Germany, for which his group has developed fully integrated and automated analysis solutions for Precision Medicine in Oncology.

Morocco

India

Dr. Fouad Alchami MD FRCPath completed a surgical rotation and membership of the Royal College of Surgeons, before joining histopathology training program in Wales, UK and becoming a fellow of the Royal College of Pathologists. He took the position of consultant histopathologist at University Hospital of Wales, Cardiff, UK where he led the Cancer Biomarker and Molecular Pathology Group, managing and reporting immunohistochemical biomarkers in multiple tumours. Dr Alchami introduced, established and conducted a countrywide reporting service for PDL1 in lung cancer in Wales. In addition he is the lead pathologist for multiple trials enabling the use of tissue for novel molecular biomarker testing and development. In his current role of senior attending physician at Sidra Medicine, affiliated with Weil Cornell Medicine – Qatar; he managed the delivery of integrated digital pathology reporting service in Sidra Medicine; one of the first fully digital units in the region. He is also quality director of all pathology. His main research activities revolve around tumour causation and evolution, grading and cancer prognostication, and clinical oncological medicine with the added role of biomarkers. He have multiple publications in these fields.

Dr. Sangeeta Desai is a Professor & Head, Pathology, Tata Memorial Centre. Her subspecialities in Surgical Pathology are Breast Cancer and Urologic Cancer. Her areas of interest in Oncology besides oncopathology include Diagnostic Molecular Pathology, Digital Pathology/AI, Telemedicine, Biorepository science, Research Bioethics. She has authored 265 publications, of which 176 are peer reviewed and contributed to 10 books. She has pioneered Clinical Molecular Diagnostics and Digital Pathology in India.

United Arab Emirates

Dr Abdulaziz AlAjlan is an accomplished and highly respected Dermatopathologist. He is one of the unique pathologists around the Kingdom and in the Middle East.

Dr Abdulaziz AlAjlan, Consultant Dermatopathologist, obtained his Bachelor Degree in Medicine from King Saud University, College of Medicine, Riyadh in 1989. He completed his fellowship in Pathology at King Saud University in 1997. He obtained his FRCPath from Royal College of Pathologists, UK in 1998. He had a specialty training fellowship in Dermatopathology from Ackerman Academy, USA in 2000.

Dr Abdulaziz AlAjlan is currently the Chairman of the Department of Pathology and Laboratory Medicine at King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia since March 2009.

Dr Abdulaziz AlAjlan has been instrumental in innovations in Digital Pathology including enhancement expertise as well as Research & Development.

He published long lists of scientific papers and books.

United Arab Emirates

United States of America